Clinical Trials Logo

Acne Scars clinical trials

View clinical trials related to Acne Scars.

Filter by:

NCT ID: NCT04807179 Enrolling by invitation - Acne Scars Clinical Trials

Clinical Study to Evaluate Alexandrite Laser for the Treatment of Acne Scars

Start date: March 8, 2021
Phase: N/A
Study type: Interventional

The intended use of the Alexandrite laser device used in this study is to assess the efficacy and safety of the Alexandrite laser device for the treatment of acne scars on skin types V and VI.

NCT ID: NCT04540900 Recruiting - Wrinkle Clinical Trials

A Study of KB301 in Adults With Shallow to Moderately Deep Facial Wrinkles and Severe Atrophic Acne Scars.

Start date: September 2020
Phase: Phase 1
Study type: Interventional

A Phase I Study of KB301 in adults with shallow-to-moderately deep facial wrinkles and severe atrophic acne scars.

NCT ID: NCT03901417 Active, not recruiting - Acne Scars Clinical Trials

Comparison of 1550nm Fractional Laser Alone Versus in Combination With Microneedling for the Treatment of Acne Scars

Start date: June 1, 2019
Phase: N/A
Study type: Interventional

Acne scarring is an unfortunate consequence of inflammatory acne vulgaris that often leads to significant cosmetic and psychosocial impacts. Although there have been many advances in the treatment of acne scarring, it remains one of the greatest challenges in cosmetic and laser dermatology. There have been a multitude of studies establishing the efficacy of non-ablative fractional laser therapy for the treatment of atrophic acne scars, and it is widely regarded as one of the best available treatments. More recently, there has been a renewed interest in controlled, non-thermal dermal injury via microneedling devices in the treatment of atrophic acne scars. Where there is a gap in the literature, however, is in the evaluation of the combination of non-ablative fractional laser resurfacing with microneedling in the treatment of atrophic acne scars. The investigators' study will compare the safety and efficacy of using non-ablative fractional laser versus a combination of microneedling and non-ablative fractional laser for atrophic acne scars using a randomized, double-blind, split-face study. The investigators' aim is to further elucidate the pathogenesis of acne scarring and the best approaches for treatment. In doing so, the investigators will study a combination approach to this complex problem in order to better serve future patients.

NCT ID: NCT03850925 Recruiting - Acne Scars Clinical Trials

Comparison of Picosecond Pulsed Nd:YAG Laser and Fractional Laser for the Treatment of Acne Scars

Start date: May 1, 2019
Phase: N/A
Study type: Interventional

This study compares the application of a picosecond 1064-nm laser with a diffractive lens array with nonablative fractional laser for the treatment of acne scarring.

NCT ID: NCT03821324 Completed - Acne Scars Clinical Trials

Clinical Evaluation of Fractional Radiofrequency for the Treatment Acne Scarring

Start date: December 11, 2018
Phase: N/A
Study type: Interventional

Prospective, single centre, evaluator-blind study of the safety and performance of fractional radiofrequency (RF) for the treatment and reduction of acne scarring. The study will evaluate the progress of 15 subjects requesting treatment of acne scarring. The study will involve three treatments on both sides of the face with 3-5 week intervals between each treatment. Subjects will be followed at 6 and 12 weeks after their last treatment. Analysis will be performed on all subjects who receive at least one treatment.

NCT ID: NCT03767153 Completed - Acne Scars Clinical Trials

Clinical Evaluation of Fractional Radiofrequency for the Treatment of Acne Scarring

Start date: November 5, 2018
Phase: N/A
Study type: Interventional

Prospective, single centre, evaluator-blind study of the safety and performance of fractional radiofrequency (RF) for the treatment and reduction of acne scarring. The study will evaluate 50 treatment sites in subjects requesting treatment of their acne scarring. The study will involve three treatments on both sides of the face with 3-5 week intervals between each treatment. Subjects will be followed at 6 and 12 weeks after their last treatment. Analysis will be performed on all subjects who receive at least one treatment.

NCT ID: NCT03522922 Completed - Acne Vulgaris Clinical Trials

Efficacy of Microneedling With Topical Vitamin C in Treatment of Acne Scarring

Start date: June 1, 2016
Phase: Phase 1/Phase 2
Study type: Interventional

This study aimed to evaluate the efficacy of dermaroller and topical vitamin C- either separate or combined- in treatment of post acne scars. prospective randomized clinical trial that was The study was a randomized controlled trial, conducted in Sohag Dermatology outpatient clinic between June 2016 and of February 2018. 30 patients with acne scars were included. All patients were informed about the entire procedure, medication, possible side effects and outcomes. A written informed consent was signed from each participant.

NCT ID: NCT03380845 Completed - Acne Scars Clinical Trials

Comparison of 1,550-nm Laser and Fractional Radiofrequency Microneedle for the Treatment of Acne Scars in Ethnic Skin

Start date: March 16, 2018
Phase: N/A
Study type: Interventional

The primary objective of this randomized, split-face, controlled study is to compare the efficacy and safety of a erbium-doped 1,550-nm non-ablative fractional laser and a bipolar fractional radiofrequency microneedle device for the treatment of atrophic facial acne scars in ethnic skin (Fitzpatrick Skin Phototypes III-VI). The hypothesis of this study is that both erbium-doped 1,550-nm non-ablative fractional laser and the bipolar fractional radiofrequency microneedle device are equally effective for the treatment of atrophic acne scars in ethnic skin (SPT III-VI). However, the bipolar fractional radiofrequency microneedle device has less adverse effects than erbium-doped 1,550-nm non-ablative fractional laser due to the absence of scattering and the absence of chromophore-specific targets - predominantly melanin - traditionally needed with laser treatments; hence the fractional radiofrequency microneedle device will have a higher safety profile in darker skin types .

NCT ID: NCT02955381 Terminated - Acne Clinical Trials

Restylane Silk Acne Scar Efficacy Evaluation Study

Start date: March 28, 2017
Phase: N/A
Study type: Interventional

Randomized, double-blind, placebo-controlled, research pilot study. 30 subjects aged 22-55 years old of all skin types will be asked to sign an informed consent form prior to any study procedures. Subjects must have at least 1 but up to 3 acne scars ≥3 mm or ≤ 10 mm located on the cheeks or forehead. Subjects will receive one treatment (Restylane® Silk or Placebo) in each scar at day 0, and Month 1 (2 total treatments per scar during the study). Subjects will be asked to come to 10 visits: Screening visit (up to 35 days prior to Baseline), Baseline (Day 0), Day 7, Day 14, Month 1, Month 2, Month 3, Month 4, Month 5, and Month 6 (study exit visit). The treatment area will be evaluated at each visit by the unblinded investigator regarding erythema, bruising, inflammation, itching, stinging/burning, brightness, fullness, smoothness, and clarity. Safety and adverse events will be captured at each visit only by the unblinded investigator.

NCT ID: NCT02216864 Active, not recruiting - Acne Scars Clinical Trials

Effect of Multiple Subcisions on Rolling Acne Scars

Start date: August 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to find out whether the use of multiple subcisions over several visits will improve the appearance of rolling acne scars compared to no treatment. This study was a pilot study designed to determine feasibility of this procedure.